Health claims comment deadline
This article was originally published in The Tan Sheet
The Consumer Healthcare Products Association requests a 60-day extension of the comment period for FDA's advance notice of proposed rulemaking on qualified health claims due to the "breadth and extent of the comments requested by the agency," trade group says Jan. 13. Extension would push deadline to March 26. ANPR was published in November (1"The Tan Sheet" Dec. 1, 2003 p. 13)...
You may also be interested in...
Codifying the current interim evidence-based ranking system for qualified health claims would preserve the current premarket review system already in place and bestow the most benefits, FDA states in an 1advance notice of proposed rulemaking on health claims published in the Nov. 25 Federal Register
The EU is pulling out all the stops to have the one-year delay to the MDR adopted before it is too late, and a crucial vote will take place on 16 April.
As US cases set to reach half a million, FDA gives green light to blood plasma trials to help meet urgent need for therapies.